Gotowe bibliografie tematyczne / Cardiovascular system – Diseases – Prevention

Gotowa bibliografia na temat „Cardiovascular system – Diseases – Prevention”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 28 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cardiovascular system – Diseases – Prevention”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cardiovascular system – Diseases – Prevention"

Wachuła, Kamila, Joanna Furman i Beata Łabuz-Roszak. "THE MEDITERRANEAN DIET IN THE PREVENTION OF CARDIOVASCULAR AND NERVOUS SYSTEM DISEASES – THE ASSESSMENT OF NUTRITIONAL KNOWLEDGE". Wiadomości Lekarskie 73, nr 7 (2020): 1448–53. http://dx.doi.org/10.36740/wlek202007125.

Pełny tekst źródła

Streszczenie:

Introduction: Following a Mediterranean diet significantly reduces the risk of cardiovascular and neurodegenerative diseases. The aim of the study was to assess nutritional knowledge among adult residents of the Silesian Province on the Mediterranean diet in the prevention of cardiovascular and nervous system diseases. Material and methods: The study was conducted using an anonymous self-made questionnaire. 190 adults from the Silesian Province participated in the study. Results: The respondents had a good or sufficient level of knowledge on the Mediterranean diet. Respondents as the benefits of using the Mediterranean diet more often indicated a reduction in the risk of cardiovascular diseases than prevention of nervous system diseases. Conclusions: The inhabitants of Silesian Province have a fairly good level of knowledge on the preventive use of the Mediterranean diet. Public knowledge on the prevention of cardiovascular diseases, as well as knowledge on the principles of the Mediterranean diet, and on the benefits of its use, can reduce the incidence of cardiovascular and nervous system diseases.

Style APA, Harvard, Vancouver, ISO itp.

Shaukatovna, Ismatova Marguba. "PREVENTION AND DIAGNOSIS OF CIRCULATORY DISEASES IN OLD AGE". American Journal of Medical Sciences and Pharmaceutical Research 04, nr 03 (1.03.2022): 56–58. http://dx.doi.org/10.37547/tajmspr/volume04issue03-11.

Pełny tekst źródła

Streszczenie:

The heart is a biological pump that moves blood through a closed system of vessels, pumping about 6 litres of blood every minute. Age-related changes in the circulatory system in old age severely limit its adaptive capacity and create conditions for developing diseases. In old and old people, the number of active capillaries per unit area is significantly reduced. Tissues and organs cease to receive the nutrients and oxygen they need, leading to starvation and disease. Cardiovascular disease is the most common cause of death in humans.

Style APA, Harvard, Vancouver, ISO itp.

Ilyés, István, Zoltán Jancsó i Attila Simay. "Trends and current questions of cardiovascular prevention in primary health care". Orvosi Hetilap 153, nr 39 (wrzesień 2012): 1536–46. http://dx.doi.org/10.1556/oh.2012.29442.

Pełny tekst źródła

Streszczenie:

Although an impressive progress has been achieved in the treatment of cardiovascular diseases, they are at the top of the mortality statistics in Hungary. Prevention of these diseases is an essential task of the primary health care. Cardiovascular prevention is carried out at primary, secondary and tertiary levels using risk group and population preventive strategies. The two main tasks of primary cardiovascular prevention are health promotion and cardiovascular disease prevention, and its main programs are ensuring healthy nutrition, improving physical training and accomplishing an anti-smoking program. The essential form of secondary prevention is the screening activity of the primary health care. The majority of cardiovascular risk factors can be discovered during the doctor–patient consultation, but laboratory screening is needed for assessing metabolic risks. The official screening rules of the cardiovascular risk factors and diseases are based on diagnostic criteria of the metabolic syndrome; however, nowadays revealing of global cardiometabolic risks is also necessary. In patients without cardiovascular diseases but with risk factors, a cardiovascular risk estimation has to be performed. In primary care, there is a possibility for long term follow-up and continuous care of patients with chronic diseases, which is the main form of the tertiary prevention. In patients with cardiovascular diseases, ranking to cardiovascular risk groups is a very important task since target values of continuous care depend on which risk group they belong to. The methods used during continuous care are lifestyle therapy, specific pharmacotherapy and organ protection with drugs. Combined health education and counselling is the next element of the primary health care prevention; it is a tool that helps primary, secondary and tertiary prevention. Changes needed for improving cardiovascular prevention in primary care are the following: appropriate evaluation of primary prevention, health education and counselling, renewal of the cardiovascular screening system based on the notion of global cardiometabolic risk, creating a unified cardiovascular prevention guideline, and operating primary care cardiovascular prevention within the framework of an integrated prevention system. Orv. Hetil., 2012, 153, 1536–1546.

Style APA, Harvard, Vancouver, ISO itp.

Przybylska, Sylwia, i Grzegorz Tokarczyk. "Lycopene in the Prevention of Cardiovascular Diseases". International Journal of Molecular Sciences 23, nr 4 (10.02.2022): 1957. http://dx.doi.org/10.3390/ijms23041957.

Pełny tekst źródła

Streszczenie:

Cardiovascular diseases (CVDs) are the leading cause of human mortality worldwide. Oxidative stress and inflammation are pathophysiological processes involved in the development of CVD. That is why bioactive food ingredients, including lycopene, are so important in their prevention, which seems to be a compound increasingly promoted in the diet of people with cardiovascular problems. Lycopene present in tomatoes and tomato products is responsible not only for their red color but also for health-promoting properties. It is characterized by a high antioxidant potential, the highest among carotenoid pigments. Mainly for this reason, epidemiological studies show a number of favorable properties between the consumption of lycopene in the diet and a reduced risk of cardiovascular disease. While there is also some controversy in research into its protective effects on the cardiovascular system, growing evidence supports its beneficial role for the heart, endothelium, blood vessels, and health. The mechanisms of action of lycopene are now being discovered and may explain some of the contradictions observed in the literature. This review aims to present the current knowledge in recent years on the preventive role of lycopene cardiovascular disorders.

Style APA, Harvard, Vancouver, ISO itp.

Przerwa, Filip, Arnold Kukowka, Katarzyna Kotrych i Izabela Uzar. "Probiotics in prevention and treatment of cardiovascular diseases". Herba Polonica 67, nr 4 (1.12.2021): 77–85. http://dx.doi.org/10.2478/hepo-2021-0026.

Pełny tekst źródła

Streszczenie:

Summary Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment.

Style APA, Harvard, Vancouver, ISO itp.

Ololenko, Matvey, Diana Baizuldinova, Ibad Mursalov, Karina Dosalieva, Zalina Kurshalieva i Olga Malyugina. "Prevention of Cardiovascular Diseases in Patients of Certain Risk Groups". Journal of Complementary Medicine Research 14, nr 1 (2023): 104. http://dx.doi.org/10.5455/jcmr.2023.14.01.20.

Pełny tekst źródła

Streszczenie:

The article is devoted to the consideration of issues related to the organization of prevention of cardiovascular diseases in patients of certain risk groups. According to the researcher, these are preventive measures with their competent implementation that can reduce the risk of morbidity, and also increase the survival of certain groups of patients, especially those suffering from concomitant diseases. Measures in this area should include timely diagnosis of the health status of such patients with their attribution to a certain risk group, as well as the development of an individual plan for drug therapy, diet and physical activity, which should take into account the specifics of the patient’s health. All of the above will contribute to reducing the morbidity of the population with the disease in question and increasing the survival rate of patients suffering from concomitant diseases, since preventive measures will reduce the burden on the cardiovascular system

Style APA, Harvard, Vancouver, ISO itp.

RAPAKOV, GEORGII G., GENNADII T. BANSHCHIKOV, VYACHESLAV A. GORBUNOV i ALEKSEY V. UDARATIN. "USING MACHINE LEARNING METHODS FOR THE CORRECTION OF BEHAVIORAL RISK FACTORS FOR PREVENTION OF CARDIOVASCULAR DISEASES". Cherepovets State University Bulletin 4, nr 97 (2020): 54–68. http://dx.doi.org/10.23859/1994-0637-2020-4-97-5.

Pełny tekst źródła

Streszczenie:

The article describes machine learning methods in the correction of behavioral risk factors while preventing cardiovascular diseases. The monitoring of health saving educational space in the regional system of medical prevention was implemented. Applying computer modeling the authors developed a model of binding rules based on the method of association rules and suggested the set of 5 logical rules for the risk factor of arterial hypertension. Decision tree method was used to induce decision rules and identify the target group to correct risk factors and increase the quality of arterial hypertension control. The present study provided the analysis and confidence estimation of the prognostic model. The results of this analysis were used to support management decisions in the regional system of preventive medicine.

Style APA, Harvard, Vancouver, ISO itp.

Andreiev, A. G. "Prevention system of brain vascular diseases in administrative-managing personnel". Neurology Bulletin XXX, nr 1-2 (15.03.1998): 38–39. http://dx.doi.org/10.17816/nb80845.

Pełny tekst źródła

Streszczenie:

Results of programme usage of pscycoprevention and psycotherapy are given in 1520 people of managing personnel of Nizhney Novgorods large industrial enterprises with different clinical variants of cardiovascular diseases. As a result of implementation of treating complex a positive dynamics of clinical, psycological and neurophysiological indices was shown. It was recommended to implement suggested therapeutic and prevention complexes in insult prevention rooms of medical stations and other out-patient and polyclinic institutions..

Style APA, Harvard, Vancouver, ISO itp.

Akhmetova, S. A., i F. F. Ishkineeva. "REFLECTIONS ON THE EFFECTIVENESS OF THE SYSTEM OF PREVENTION OF CARDIOVASCULAR DISEASES". KAZAN SOCIALLY-HUMANITARIAN BULLETIN 9, nr 5 (wrzesień 2018): 4–8. http://dx.doi.org/10.24153/2079-5912-2018-9-5-4-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Sokoła-Wysoczańska, Ewa, Tomasz Wysoczański, Jolanta Wagner, Katarzyna Czyż, Robert Bodkowski, Stanisław Lochyński i Bożena Patkowska-Sokoła. "Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review". Nutrients 10, nr 10 (21.10.2018): 1561. http://dx.doi.org/10.3390/nu10101561.

Pełny tekst źródła

Streszczenie:

Cardiovascular diseases are described as the leading cause of morbidity and mortality in modern societies. Therefore, the importance of cardiovascular diseases prevention is widely reflected in the increasing number of reports on the topic among the key scientific research efforts of the recent period. The importance of essential fatty acids (EFAs) has been recognized in the fields of cardiac science and cardiac medicine, with the significant effects of various fatty acids having been confirmed by experimental studies. Polyunsaturated fatty acids are considered to be important versatile mediators for improving and maintaining human health over the entire lifespan, however, only the cardiac effect has been extensively documented. Recently, it has been shown that omega-3 fatty acids may play a beneficial role in several human pathologies, such as obesity and diabetes mellitus type 2, and are also associated with a reduced incidence of stroke and atherosclerosis, and decreased incidence of cardiovascular diseases. A reasonable diet and wise supplementation of omega-3 EFAs are essential in the prevention and treatment of cardiovascular diseases prevention and treatment.

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Rozprawy doktorskie na temat "Cardiovascular system – Diseases – Prevention"

Neubeck, Alicia Helen. "Increasing access to secondary prevention of cardiovascular disease". Thesis, The University of Sydney, 2011. https://hdl.handle.net/2123/27329.

Pełny tekst źródła

Streszczenie:

Background: Access to secondary prevention remains disconcertingly low despite proven benefits. The objectives of this thesis were: to evaluate telehealth models of secondary prevention; to determine barriers to participation in secondary prevention; to evaluate the long-term outcomes of a previously proven telehealth model, CHOICE (Choice of Health Options In prevention of Cardiovascular Events); to determine the replicability and generalisability of CHOICE; and to determine future directions for delivery of secondary prevention. Methods: Mixed methods were utilised to achieve the objectives of this thesis. To evaluate telehealth models, a systematic review and meta-analysis process was followed. To determine the barriers to participation in secondary prevention, a systematic review and meta-synthesis process was followed; to evaluate the long-term outcomes of CHOICE, patients who had participated in the original single centre trial had a repeat assessment at four-years after their baseline assessment; to determine the replicability and generalisability of CHOICE, a multi-centre replication trial involving 270 participants was conducted; and to determine future directions for delivery of SP, both quantitative and qualitative methods, including survey and focus groups, were undertaken. Results: Telehealth based models of secondary prevention can improve access, reduce risk factors and improve quality of life in patients who do not participate in facility-based secondary prevention programs. While there are a number of barriers to participation in facility-based secondary prevention, some of which are potentially modifiable, it was clear from our review that a one-size fits all approach will not be suitable and telehealth models can provide additional options for access to secondary prevention. Results of the long-term follow-up of the single centre trial demonstrated that at four years participants in CHOICE had maintained the significant improvements that they had made at one year. In the current replication study results showed that participants were at lower baseline risk than in the previous single-centre study, but still made improvements in multiple cardiovascular risk factors. Finally, we determined that an Internet-based model of secondary prevention would suit some, but not all, patients with cardiovascular disease and may provide an additional option for patients not accessing facility-based programs Conclusion: There are multiple barriers to the uptake of secondary prevention and telehealth models can offer an evidence-based alternative to patients who do not access facility-based programs. The CHOICE program is a flexible telehealth model that provides long-term behaviour change and is readily translated into multiple clinical settings. Future work could focus on utilising new technology to increase uptake to proven secondary prevention models such as CHOICE.

Style APA, Harvard, Vancouver, ISO itp.

Loke, Wai Mun. "Cardiovascular protective effects of dietary polyphenols". University of Western Australia. School of Biomedical and Chemical Sciences, 2008. http://theses.library.uwa.edu.au/adt-WU2009.0051.

Pełny tekst źródła

Streszczenie:

Polyphenols are naturally-occurring phytochemicals, which form an integral part of the human diet. Results from epidemiological studies have associated polyphenol intake with reduced risk of cardiovascular diseases. Previous human intervention studies suggested that dietary polyphenols exert their cardioprotective effects through their antioxidant and anti-inflammatory effects. While most in vitro experiments have not accounted for the bioavailability and metabolism of these polyphenols, our work has provided direct evidence, using quercetin, that metabolic transformation, together with bioavailability, exert profound effects on bioactivity. We examined the effect of quercetin and its major metabolites on the production of pro-inflammatory eicosanoids by human leukocytes. Studies comparing free radical scavenging, antioxidant activity and eicosanoid production demonstrate that there are different structural requirements for antioxidant and anti-inflammatory activity. We also investigated the effect of metabolic transformation on flavonoid bioactivity by comparing the activity of quercetin and its major metabolites to inhibit inflammatory eicosanoid production from human leukocytes. Quercetin was a potent inhibitor of leukotriene B4 formation in leukocytes (IC50 ~ 2µM), and its activity was dependent on specific structural features, particularly the 2,3 double bond of the C ring. Functionalisation of the 3'-OH group with either methyl or sulfate reduced inhibitory activity up to 50% while a glucuronide substituent at the 3-OH effectively removed the leukotriene B4 inhibitory activity. The major quercetin metabolite quercetin-3'-O-sulfate retained considerable lipoxygenase inhibitory activity (IC50 ~ 7 µM) while quercetin-3-O-glucuronide maintained antioxidant activity but had no lipoxygenase inhibitory activity at physiologically relevant concentrations. We conclude that structural modification of quercetin due to metabolic transformation had a profound effect on bioactivity, and that the structural features required for antioxidant activity of 8 quercetin and related flavonoids were unrelated to those required for inhibition of inflammatory eicosanoids.

Style APA, Harvard, Vancouver, ISO itp.

Chamnan, Parinya. "Pragmatic approaches for identifying and treating individuals at high risk of diabetes and cardiovascular disease". Thesis, University of Cambridge, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.609168.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Masoud, Mohamed Abdulsalam. "Validation of a recently proposed equation for the estimation of small, dense LDL particles from routine lipid measures in a population of mixed ancestry South Africans". Thesis, Cape Peninsula University of Technology, 2016. http://hdl.handle.net/20.500.11838/2490.

Pełny tekst źródła

Streszczenie:

Thesis (MSc (Biomedical Technology))--Cape Peninsula University of Technology, 2016.
Cardiovascular diseases (CVD) are the leading cause of global mortality, of which over 75% occurred in low- and middle-income countries such as South Africa. The lipid profile, specifically decreased levels of high density lipoprotein cholesterol (HDL-C), elevated triglyceride levels and the presence of small-dense low density lipoprotein (sdLDL) has been reported associated with CVD. An increased number of sdLDL is also common in metabolic syndrome (MetS), visceral obesity and diabetes mellitus, the last a known risk factor for CVD. The modification of low density lipoprotein (LDL) size, or number of sdLDL particles, has been reported to significantly reduce CVD risk, but not conclusively so and needs further investigation. In this regard, sdLDL particles are seldom estimated routinely for clinical use because of financial and other limitations. Currently, an alternative approach for estimating sdLDL is to use equations derived from routine lipid measures, as has been proposed by several groups. However, there is a need for extensive evaluation of this equation across different ethnic and disease groups, especially since reports showed an inadequate performance of the equation in a Korean population. The aim of this study was to assess the performance of a recently proposed equation for the estimation of sdLDL in healthy and diabetic mixed ancestry South Africans. Furthermore, we also investigated the role of sdLDL as a cardiometabolic risk factor, as measured against known risk factors such as the glycemic and lipid profiles.

Style APA, Harvard, Vancouver, ISO itp.

Ng, Chun-man, i 吳晉文. "Effect of statins on prevention of cardiovascular diseases in Asian population: a systematic review ofrandomized, controlled trials". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48425060.

Pełny tekst źródła

Streszczenie:

Background Cardiovascular disease (CVD) is the worldwide leading cause of death among non-communicable diseases and results in a huge burden of mortality and morbidity. China, a rapidly growing East Asian country, has the world largest population and is facing an increasing burden. Incidence of CVD is lower in China than in Western countries. There are more strokes, especially hemorrhagic strokes, but less coronary heart disease (CHD) in China than in Western countries. Statin, a first-choice drug for lowering low-density lipoprotein cholesterol (LDL-C), has been shown to be effective in preventing CVD and is widely used in Western countries. However, it is not known whether the same can be applied to Asian countries, where the incidence of CVD is lower and ischemic events are rarer. The aim of this systematic review is to evaluate the effectiveness of statin for prevention of CVD in East Asian populations. Methods A systematic review was conducted by searching for randomized controlled trials from 3 databases (PubMed, MEDLINE and Cochrane Trial) for prevention of CVD comparing statin with usual care or placebo in East Asian population. Data on CVD events (deaths, CHD and cerebrovascular events, rehospitalization and revascularization) and serum lipid levels (total cholesterol (TC), LDL-C, high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG)) were extracted. Risk ratios of CVD events and change in serum lipid level were tabulated. The relationship between change in serum lipid level and mortality and incidence of CVD events were also explored. Results Fourteen studies were included, with most of them (9 studies) done in Japan. Overall, statins did not significantly reduce risk of mortality, CHD events, cerebrovascular events, revascularization and rehospitalization due to CHD. However, statins consistently lowered the risk of angina-related rehospitalization by 53% (95% confidence interval (CI) 23% to 71%) and 64% (95% CI 11% to 86%) respectively in 2 studies. There was a consistent reduced risk of composite CVD events by 34% (95% CI 5% to 55%) to 54% (95% CI 6% to 41%) in 4 studies for secondary prevention. In terms of change in lipid levels, TC and LDL-C were significantly reduced by 8% to 31% and 14% to 41% respectively with statin treatment. Change in HDL-C and TG were not consistent across studies. Lowering of TC and LDL-C level was correlated with the reduction in composite CVD and CHD events. Conclusion The use of statins in East Asian populations to prevent CVD may not be as effective as in Western countries, because of the lower baseline risk and different patterns of CVD. As the prevalence of CVD risk factors increases, the incidence of CVD will increase and the pattern of CVD may change, so careful monitoring is needed. More importantly, most of the studies included had small sample sizes, short follow-up periods and/or low methodological quality, which might contribute to the inconsistent findings. A further large-scale randomized controlled trial should be done to confirm the benefits of statins among Chinese.
published_or_final_version
Public Health
Master
Master of Public Health

Style APA, Harvard, Vancouver, ISO itp.

Ren, Siqian, i 任思倩. "The effects of polyphenols from grapes to prevent cardiovascular disease". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193801.

Pełny tekst źródła

Streszczenie:

Background: Cardiovascular disease is the leading cause of mortality and morbidity in the world and has something to do with daily diet. The polyphenol is the most abundant compound in daily diet, including grape. The red wine was rich in polyphenol because of composing much grape. Early study has already confirmed the “French Paradox” in cardiovascular protection power, which shed light on the dietary modulation on disease. Objective: The main objective of the study was to evaluate the effect of products containing polyphenol such as red wine extract, grape juice and grape extract tablets or powder on cardiovascular disease risk factors. It mainly examined relationship between polyphenol and serum lipid in addition to blood pressure. Methods: Studies working on effects of grape extract products on cardiovascular disease were searched from electronic resources MEDLINE and EMBASE. Nine clinical controlled trials were identified through PubMed and Ovid. CONSORT guideline and Jadad Score were used to appraise the quality of trials. Weighing two assessment guidelines, a total of three studies were in good quality, one was in bad quality while the rest four were fair to middle. Results: The changes before and after intervention on serum lipid and blood pressure were contradictory. Some studies found polyphenol was statistically significant protective factors, while some did not find it siginificant but still showed a protective effect. One study found polyohenol had no effect on cardiovascular disease risk factors. Conclusion: The prevention of polyphenol was not consistent in nine trials and there is no sufficient and strong evidence supporting its cardiovascular protection effect given that the study design of each trial differed. It was not recommeded to use grape polyphenol as cardiovascular protect products. There were limitations and weakness of current study on the association of polyphenol and cardiovascular disease. Further research on this topic is required, both in vivo and in vitro.
published_or_final_version
Public Health
Master
Master of Public Health

Style APA, Harvard, Vancouver, ISO itp.

Chow, Wai-sum, i 周瑋琛. "A systematic review on the role of chocolate in the prevention of cardiovascular diseases". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B47560198.

Pełny tekst źródła

Streszczenie:

Background: Research studies in recent years suggested possible role of dark chocolate in preventing cardiovascular diseases due to its high flavonal and procyanidins contents. Whether there is clear clinical benefit and the mechanisms mediating such benefits is controversial. Objective: This systematic review aims to comprehensively examine the current clinical evidence regarding effectiveness and the possible mechanisms of chocolate in reducing the risk and / or surrogate markers of cardiovascular diseases. Methods: Comprehensive electronic literature search was performed using Ovid, Medline and Cochrane database. Only English language literatures published during year 1950 - 2010 were reviewed. All intervention studies and observational studies of adult human subjects taking white or dark chocolate in relation to outcomes of cardiovascular risk were included. All review articles and meta-analysis were also included. Clinical diagnosis of cardiovascular disease and surrogate markers including blood pressure, vascular endothelial function as measured by flowed mediated vasodilation, and blood biomarkers such as lipid profile were studied as outcome variables. Results: The review outlines recent observational and interventional studies and meta-analysis to give an overview of the topic. For observational studies, a cohort studies and two case control studies were found. The observational studies showed that dark chocolate consumption was inversely associated with blood pressure, cardiovascular mortality and C-reactive protein. All interventional studies searched showed that dark chocolate increased FMD and improved platelet function. However, the effects of cocoa on intermediate outcomes such as blood pressure, antioxidant capacity and inflammatory marker changes were inconsistent among interventional studies. Three interventional studies indicated that there was a dose-dependent improvement in immediate outcome variables after 1 month or even 2 hours acute consumption of dark chocolate with procyanidins or cocoa drink with flavonol. However, publication bias and potential conflict of interests may be a potentially important factor in interpreting study results in the current literature. Conclusions: There are some clinical and scientific evidences that consumption of dark chocolate produces positive cardiovascular benefits. A small amount of dark chocolate may be good for the heart. However, gaps in our knowledge such as a lack of long-term RCT in clinical outcomes must be filled in before recommending habitual dark chocolate consumption for reduction of cardiovascular risk.
published_or_final_version
Community Medicine
Master
Master of Public Health

Style APA, Harvard, Vancouver, ISO itp.

Anchala, Raghupathy. "Management of hypertension and prevention of cardiovascular diseases in India : the role of decision support systems". Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648283.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Maeng, Jae G., i Stephen A. Geraci. "Cardiovirology Clinic for Primary Prevention in HIV Patients: a Quality Improvement Assessment". Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/asrf/2019/schedule/191.

Pełny tekst źródła

Streszczenie:

INTRODUCTION With effective highly active antiretroviral therapy (HAART), individuals with human immunodeficiency virus (HIV) infection now enjoy life expectancies approaching those of uninfected individuals. Prolonged longevity has increased the prevalence of non-communicable comorbidities within the HIV patient population. HIV is a known independent risk factor for atherosclerotic cardiovascular disease (ASCVD), imparting a 1.5-2 -fold higher incidence of major adverse cardiovascular events (MACE) on infected patients. Deaths from ASCVD have increased as a result, despite a decline in total mortality. The Center of Excellence for HIV/AIDS care established a Cardiovirology Clinic (CvC) focused on providing primary and secondary preventative cardiovascular care to its patients. To date, there are no known data on the efficacy of such an intervention. We sought to define the performance of this care model for primary prevention. METHODS Unique CvC patients (n=68) with a treatment delivery window between September 1, 2017 to August 31, 2018 were identified through billing records. All patients were receiving HAART as prescribed by their infectious disease provider. Those with established ASCVD (n=10) were excluded from analysis to limit the study to primary prevention patients. We collected data on ASCVD risk factors (family history of premature ASCVD and personal histories of smoking, diabetes, hypertension [with degree of control], dyslipidemia, drug and alcohol use, and exercise) from the electronic health record. Body-mass index and systolic (SBP) and diastolic (DBP) blood pressures were also collected. Laboratory values including CD4 cell count, HIV-1 viral load, proteinuria, glomerular filtration rate, total cholesterol (TC), triglycerides (TG), and high (HDL) and low density (LDL) lipoprotein were included in the data collection. Estimates of 5-year risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or need for major revascularization was calculated using the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) equations. Patient data were de-identified. Two-tailed, paired T-testing was performed for each factor comparing the initial and most recent follow-up values. Significance was defined as p value <0.05. RESULTS Using univariate analysis, reductions in D:A:D risk (relative 32.01%, absolute 1.49%, p CONCLUSION In this initial assessment, treated HIV patients appeared to enjoy meaningful reductions in MACE risk through the preventive care they received in this clinic, suggesting that CvCs could be a partial solution to the growing ASCVD morbidity and mortality among HIV-infected individuals. Limitations of this study include a small patient population (n=58) (limiting us to univariate analyses) and short duration of follow up (≤ 1 year). Data collection will continue annually for 4 additional years. With increasing subject numbers, multivariate analyses to determine if components of ASCVD risk reduction show interactions, and which factors, interactions and interventions impart the greatest risk reduction, will be performed in improve the quality of care.

Style APA, Harvard, Vancouver, ISO itp.

Turnbull, Fiona. "Effects of different blood pressure-lowering regimens on major cardiovascular events in major patient subgroups". Thesis, The University of Sydney, 2007. https://hdl.handle.net/2123/28142.

Pełny tekst źródła

Streszczenie:

Background Cardiovascular disease is a leading cause of mortality and morbidity worldwide. Blood pressure is the single, most important risk factor for cardiovascular disease; nearly two-thirds of all strokes and approximately half of all ischaemic heart disease events are attributable to non-optimal blood pressure. The evidence from individual randomised trials of blood pressure lowering regimens suggests that that protection from major cardiovascular events can be achieved by lowering blood pressure, even among those with so-called ‘normal’ blood pressures. However, many trials are not sufficiently powered to demonstrate modest but clinically important differences in the effects of different classes of drug on the risk of cardiovascular disease. As a result, there is considerable uncertainty about the relative effectiveness of different drug classes. Reliable and precise information about the effects of treatment is central to the management of cardiovascular risk in millions of people worldwide. The aim of the research contributing to this thesis was to generate high quality evidence about the effects of a range of blood pressure lowering regimens on major cardiovascular outcomes in important patient subgroups. Methods The research uses prospectively-planned overviews (meta-analyses) of large randomised trials to generate precise estimates of treatment effect. The trials contributing to the overviews were those participating in the Blood Pressure Lowering Treatment Trialists’ Collaboration. Data from all relevant trials were submitted to the Collaboration Secretariat based at the George Institute for International Health in Sydney, Australia for inclusion in analyses. Data were combined using standard meta-analytic techniques and reported as pooled point estimates and 95% confidence intervals for the six pre-specified primary outcomes of stroke, coronary heart disease, heart failure, cardiovascular death and total mortality. The analyses comprised three main components: (1) one main set of overview analyses to examine treatment effects in the overall study population; (2) three sets of overview analyses to examine treatment effects in subgroups of younger and older patients, men and women and patients with and without diabetes; and (3) a series of post-hoc analyses (meta-analysis and meta-regression analysis) to examine the relative contributions of blood pressure-dependent and independent effects of two main classes of blood pressure drugs, ACE-I inhibitors and angiotensin receptor blockers.

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Książki na temat "Cardiovascular system – Diseases – Prevention"

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

S, Alwan Alaʻdin A., i World Health Organization. Regional Office for the Eastern Mediterranean., red. Prevention and control of cardiovascular diseases. Alexandria, Egypt: World Health Organization, Regional Office for the Eastern Mediterranean, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Healey, Justin. Cardiovascular health. Thirroul, N.S.W: Spinney Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Understanding cardiovascular diseases. Wyd. 2. Milton Keynes: Open University, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Labarthe, Darwin. Epidemiology and prevention of cardiovascular diseases: A global challenge. Wyd. 2. Sudbury, Mass: Jones and Bartlett Publishers, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Epidemiology and prevention of cardiovascular diseases: A global challenge. Wyd. 2. Sudbury, Mass: Jones and Bartlett Publishers, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Epidemiology and prevention of cardiovascular diseases: A global challenge. Gaithersburg, Md: Aspen Publishers, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Kåre, Berg, i Nora Audrey Hart 1936-, red. Cardiovascular diseases: Genetics, epidemiology, and prevention. New York: Oxford University Press, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Hobbs, Richard, M.R.C.G.P. i Arroll Bruce, red. Cardiovascular risk management. Chichester, West Sussex, UK: John Wiley & Sons, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Physical activity and cardiovascular disease prevention. Sudbury, Mass: Jones and Bartlett, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Części książek na temat "Cardiovascular system – Diseases – Prevention"

Boccara, F., i A. Cohen. "Coronary Artery Disease and Stroke in HIV-Infected Patients: Prevention and Pharmacological Therapy". W HIV Infection and the Cardiovascular System, 163–84. Basel: KARGER, 2003. http://dx.doi.org/10.1159/000073182.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Messerli, F. H., i E. Grossman. "The Effects of ß-Blockade on the Cardiovascular System — Not all ß-Blockers are Created Equal". W Prevention of Disease Progression Throughout the Cardiovascular Continuum, 29–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56525-0_3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Krishnan, Anand, i Lorraine Oldridge. "Role of Surveillance Systems and Health Observatories for an Intelligent Public Health Approach to Cardiovascular Diseases". W Public Health Approach to Cardiovascular Disease Prevention & Management, 157–66. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/b23266-20.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Raczynski, James M., Martha M. Phillips, Carol E. Cornell, M. Janice Gilliland, Bonnie Sanderson i Vera Bittner. "Cardiovascular Diseases". W Handbook of Health Promotion and Disease Prevention, 231–59. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4789-1_12.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Claas, Steven A., Stella Aslibekyan i Donna K. Arnett. "Genetics of Cardiovascular Disease". W Prevention of Cardiovascular Diseases, 117–27. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_13.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Huffman, Mark D., i Sidney C. Smith. "Global Burden of Non-Communicable, Chronic Diseases". W Prevention of Cardiovascular Diseases, 1–11. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Zeytinoglu, Meltem, i Elbert S. Huang. "Diabetes: A Primary Health Care Approach". W Prevention of Cardiovascular Diseases, 91–99. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_10.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Perk, Joep. "Risk Factors in Childhood and Youth". W Prevention of Cardiovascular Diseases, 101–8. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Précoma, Dalton Bertolim, Jorge Ilha Guimarães i Antonio Felipe Simão. "Other Determinants of Cardiovascular Diseases: Social, Globalization, and Urbanization". W Prevention of Cardiovascular Diseases, 109–15. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_12.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Huang, Helen C., Puja K. Mehta i C. Noel Bairey Merz. "Cardiovascular Disease in Women: An Update". W Prevention of Cardiovascular Diseases, 129–41. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_14.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Cardiovascular system – Diseases – Prevention"

Narasimhan, Lakshmi, Di Wu i Narinder Gill. "Meta-Analysis of Clinical Cardiovascular Data towards Evidential Reasoning for Cardiovascular Life Cycle Management". W InSITE 2007: Informing Science + IT Education Conference. Informing Science Institute, 2007. http://dx.doi.org/10.28945/3147.

Pełny tekst źródła

Streszczenie:

The cardiovascular disease is one of the serious and life-threatening diseases in the developed world. One aspect of medical treatment is using drugs with blood pressure reducing or cholesterol lowering functions. Importantly, such treatment needs to be individually tailored and is significantly correlated to the particular conditions of individual patients. However, such pathologies and mechanisms are still only under investigation. Several novel and unique computational methods, called meta-analyses techniques, for formatting and analyzing a wide variety of cardiac datasets are discussed in this paper with the aim to building cardiovascular database and related patient life-cycle management services. In this paper we also present an overview of a second order inference engine underlying the meta-analyses, which yields evidenced-based reasoning that is more likely to better assist decision-making on the effectiveness of cardiovascular treatment than what is available currently. Furthermore, the software architecture and other details of such a medical informatics system tailored to cardiovascular disease are also described. Research and development work on this project yields itself to application to many other areas, such as disease control and prevention in Epidemiology, and dietics. The system can therefore make a profound impact to medical informatics.

Style APA, Harvard, Vancouver, ISO itp.

Vyunova, A. A., I. V. Vlasova i A. A. Lomteva. "EMPLOYEES OF ENTERPRISES SERVED BY THE FMBA OF RUSSIA PROFESSIONAL UNSUITABILITY MONITORING AS PROFESSIONAL LONGEVITY MAINTAINING SYSTEM ELEMENT". W The 4th «OCCUPATION and HEALTH» International Youth Forum (OHIYF-2022). FSBSI «IRIOH», 2022. http://dx.doi.org/10.31089/978-5-6042929-6-9-2022-1-54-57.

Pełny tekst źródła

Streszczenie:

Relevance: Experienced, highly qualified specialists are the main personnel potential of the serviced enterprises. So, in the State Corporation «Rosatom» the training of one such employee requires at least 10 million rubles. Thus, the prevention of medical contraindications is not only important social task, but also provides the reduction in economic costs in all industries, critical ones including. Goal: To determine the most important areas for medical contraindications prevention in the framework of professional longevity maintaining. Materials and methods: The study included the results of periodic medical examinations of more than 300,000 employees conducted on the basis of 83 medical organizations subordinate to the FMBA of Russia. Results: The most common causes of unsuitability of workers are: eye diseases, cardiovascular diseases, pathology of hearing organ, cancer, diseases of digestive system. Conclusions: Professional unsuitability levels and causes system assessment introduction makes possible to determine the most important areas for prevention of medical contraindications within the framework of professional longevity system maintaining.

Style APA, Harvard, Vancouver, ISO itp.

Agzamova, G. S., N. U. Ibragimova i Yu A. Abdieva. "PREVENTION ISSUES OF OCCUPATIONAL AND PRODUCTION-RELATED DISEASES IN MINING INDUSTRY WORKERS". W The 16th «OCCUPATION and HEALTH» Russian National Congress with International Participation (OHRNC-2021). FSBSI “IRIOH”, 2021. http://dx.doi.org/10.31089/978-5-6042929-2-1-2021-1-12-15.

Pełny tekst źródła

Streszczenie:

Abstract: Protecting and promoting the health of workers in the mining industry is one of the most important problems of occupational pathology and health care. The structure and levels of prevention of occupational diseases are directly dependent on harmful and adverse factors of the production environment and labor process, adequately reflecting the state of production. Purpose: to study the issues of prevention of occupational and production-related diseases of mining and metallurgical plant workers. Research materials and methods: a dynamic observation of the health status of workers in the main industries of the mining and metallurgical plant (800 workers) was carried out. 92 patients with silicosis were examined. Results: Up to 92.8% of first-time occupational diseases are detected during periodic medical examinations. The prevailing sociomatic pathology is cardiovascular pathology, namely, arterial hypertension and diseases of the musculoskeletal system, mainly osteochondrosis of the spine. Prevalence of silicosis was observed in individuals with little professional experience (from 5 years old), young age and primary detection of patients in stage II silicosis, which was accompanied by respiratory failure. Conclusions: The prevention programme developed will ensure a high level of health care in terms of early diagnosis, rehabilitation and secondary prevention of both occupational and occupational diseases.

Style APA, Harvard, Vancouver, ISO itp.

Siswanto, Boby. "Problem Identification on Cardiovascular Disease Prevention using Artificial Intelligence: A Literature Review". W 2022 International Conference on Informatics, Multimedia, Cyber and Information System (ICIMCIS). IEEE, 2022. http://dx.doi.org/10.1109/icimcis56303.2022.10017552.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Киреева, Виктория, Viktoriya Kireeva, Г. Лифшиц, G. Lifshic, Н. Кох, N. Koh, Ю. Усольцев, Yu Usolcev, Константин Апарцин i Konstantin Apartsin. "Advantages of a personalized approach to the prevention and treatment of cardiovascular diseases in the staff of the INC Of the SBRAS". W Topical issues of translational medicine: a collection of articles dedicated to the 5th anniversary of the day The creation of a department for biomedical research and technology of the Irkutsk Scientific Center Siberian Branch of RAS. Москва: INFRA-M Academic Publishing LLC., 2017. http://dx.doi.org/10.12737/conferencearticle_58be81ec9ed47.

Pełny tekst źródła

Streszczenie:

Purpose of the study. To test the functional associations of polymorphic variants of genes in the regulation of blood pressure and vascular tone in employees of the ISC SB RAS. Materials and methods. The study involved patients, employees of the ISC SB RAS, being under care of the outpatient clinic of the Hospital of the ISC SB RAS. During routine laboratory testing the patients were taken 2 ml of blood for genetic analysis and further molecular genetic study on “Hypertension”, “Endothelial dysfunction”, “Pharmacogenetics”, “Inflammatory response” panels. Results. In the analysis of 12 genes coding for key proteins of hormonal enzyme blood pressure regulation systems, polymorphism of CYP11B2 showed statistically significant correlation with the presence of arterial hypertension, which makes its further study promising. The presence of allele C showed protective significance in relation to the development of hypertension with OR = 0,247. When checking associations of functional polymorphic variants of genes, the products of which are involved in the regulation of vascular tone, with hypertension in patients younger than 50 years old we found association of T/T rs5443GNB3 genotype with the debut of hypertensive disease under the age of 50. The data obtained allow the doctor to choose the most personalized and effective safe drug from certain groups, as well as its dose for employees having passed molecular genetic testing. These data can reveal predisposition to the most widespread and socially significant diseases in the surveyed subjects and provide specific personalized recommendations for the prevention of these diseases.

Style APA, Harvard, Vancouver, ISO itp.

Yeh, Ming Hua, Paul C. P. Chao i Rajeev Pandey. "A New On-Chip Real-Time Algorithm for Non-Invasive Cuffless Blood Pressure Estimation Using PPG Sensor". W ASME 2019 28th Conference on Information Storage and Processing Systems. American Society of Mechanical Engineers, 2019. http://dx.doi.org/10.1115/isps2019-7475.

Pełny tekst źródła

Streszczenie:

Abstract Blood pressure is a basic physiological quantity and prolonged abnormal blood pressure which will precipitate different kinds of cardiovascular diseases. The early detection of hypertension is extremely important for the prevention and cure of cardiovascular diseases. This study proposes a new on-chip real-time algorithm for non-invasive cuffless blood pressure estimation using PPG Sensor (PPG). The algorithm is implemented in the integrated chip with chip area of 3.97mm2 and fabricated via TSMC T18 process. The experimental result shows that the overall power consumption of the chip is 15.62 mW. Finally, the blood pressure measurement platform has been developed with GUI for long-term continuous cuffless BP measurement. The non-invasive blood pressure sensor is applied to the wrist artery of 44 subjects for sensing the PPG pulsation of the blood vessel. Measurement results shows that the maximum error in the BP measurement is ±6 mmHg. Which is less than 8 mmHg, defined by the Advancement of Medical Instrumentation (AAMI) and British Hypertension Society (BHS) standard.

Style APA, Harvard, Vancouver, ISO itp.

Lee, Jihwan, Jaehyo Jung i Youn Tae Kim. "Design and development of mobile cardiac marker monitoring system for prevention of acute cardiovascular disease". W 2011 IEEE Sensors. IEEE, 2011. http://dx.doi.org/10.1109/icsens.2011.6126933.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Falcão, Fernando Benevides, Guilherme Diogo Silva, Cesar Castello Branco Lopes, Aston Marques Midon i Carlos André Oshiro. "Simultaneous anterior and posterior circulation stroke secondary to large-vessel atherosclerotic disease associated with persistent trigeminal artery: a case report". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.675.

Pełny tekst źródła

Streszczenie:

Context: Cardioembolic events are the main cause of simultaneous anterior and posterior circulation stroke. Anatomical variants of the circle of Willis represent another rare mecanism. Persistent trigeminal artery is a carotid–vertebrobasilar anastomosis related to an increased risk of aneurysms, vascular malformations and stroke. Case report: A 67-year-old diabetic man was brought to the emergency department with a history of sudden onset of left hemiparesis. Neurologic finginds showed a hemiparesis, hemianesthesia and heminegligence (all left sided), right hemiataxia and a dysarthria. Brain Magnetic Resonance study revealed a isquemic stroke in right middle cerebral artery, right posterior cerebral artery (PCA) and bilateral superior cerebellar arteries (SUCA). Computed tomography angiography showed a right internal carotid artery oclusion and a persistent trigeminal artery. Causitive Classification System (CCS) revealed a large-vessel atherosclerotic stroke. A non-habitual simultaneous affection of PCA and SUCA resulted from a carotid artery embolization associated with anterior and posterior territories anostomosis by the persistent trigeminal artery. Secondary prevention consisted of aspirin 100mg/day and cardiovascular risk factor control. The patient remained free from others cardiovascular events, in rehabilitation, at the moment, in category 3 from the Ranking Modified Scale. Conclusions: The presence of a persistent trigeminal artery, in the context of a internal carotid oclusion, can chance our stroke-mecanism interpretation. Simultaneous anterior and posterior circulation stroke are compatible with large-vessel aterosclerotic disease.

Style APA, Harvard, Vancouver, ISO itp.

Mayoral-Peña, K., A. Hambleton-Fuentes i E. Caloca-Lafont. "UNDERGRADUATE STUDENTS' INVOLVEMENT IN DIGITAL PATIENT-EDUCATION STRATEGY AMID COVID-19 PANDEMIC". W The 7th International Conference on Education 2021. The International Institute of Knowledge Management, 2021. http://dx.doi.org/10.17501/24246700.2021.7163.

Pełny tekst źródła

Streszczenie:

The COVID-19 pandemic generated relevant challenges in educating future physicians and brought attention back to the vulnerability caused by non-communicable diseases (NCDs), such as cancer, emphysema, and cardiovascular affections. Due to the risk of the 2019 Coronavirus contagion, the patient-based education strategies were put on hold, as they were face-to-face. Also, there was an urgent need to develop strategies that used new technologies to offer efficient and fast medical content to the non-specialized public. To overcome this situation, we involved undergraduate students of medicine in developing scientific content and infographics about the prevention and early diagnosis of cancer for a mobile application. The objective of this study was to assess the learning impact generated by the creation of digital patient-education materials. Five medical students enrolled in the Pathophysiology of Respiratory System course at Tecnologico de Monterrey were recruited as participants in the educational strategy with weekly sessions for four months. The following pedagogical tools were used during the intervention: project-based learning, challenge-based learning, engagement, service learning, science outreach, design thinking, and mentoring. Ten infographics for the mobile application were created after this experience. Also, a qualitative and transversal analysis of the undergraduates' learning was implemented using a focus group session as an instrument to evaluate the mentioned strategy's impact. As a relevant finding, we observed a high level of engagement, improvement in communication skills, and ethical reflections among the students. After the app is completed, we plan to create a social startup to generate more content about NCDs to promote prevention and early diagnosis. Educational strategies involving medical undergraduates in social projects have two beneficial outcomes: the student internalizes significant knowledge and positively impacts society's health. This project aims to inspire educators to empower students to develop real-life solutions as part of their college activities. Keywords: Educational innovation, medical education, patient-education strategy, digital technology development, pandemic adaptations, cancer education

Style APA, Harvard, Vancouver, ISO itp.

Bai, Ningzhu. "Advances in the Prevention of Cardiovascular Diseases by Phytosterol". W the third International Conference. New York, New York, USA: ACM Press, 2019. http://dx.doi.org/10.1145/3340037.3340073.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Cardiovascular system – Diseases – Prevention"

FEDOTKINA, S. A., O. V. MUZALEVA i E. V. KHUGAEVA. RETROSPECTIVE ANALYSIS OF THE USE OF TELEMEDICINE TECHNOLOGIES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF HYPERTENSION. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/978-0-615-67320-2-4-22.

Pełny tekst źródła

Streszczenie:

Introduction. The economic losses associated with disability due to diseases of the circulatory system, as well as the costs of providing medical care to patients suffering from heart and vascular diseases, are increasing annually. The state preventive measures currently being carried out are of a delayed nature. The results of the medical examination of the population of the Russian Federation in recent years (2015-2019) indicate that the incidence of cardiovascular diseases, including hypertension, is at a fairly high level. In the middle of the last century, the Concept of risk factors for the development of chronic non-communicable diseases were formulated, in the structure of which cardiovascular diseases, including arterial hypertension, occupies one of the primary positions. The concept is based on the results of promising epidemiological studies, and, at present, is a methodological basis for planning and organizing primary prevention of cardiovascular diseases. The purpose of the study. Based on the analysis of literary sources (including foreign ones) containing experience in the use of telemedicine technologies, to assess their significance for the prevention, diagnosis and treatment of hypertension, as well as forecasting improvements in the quality of medical care when adapting to the use of clinical recommendations. Materials and methods. The article provides an analytical review of the use of modern telemedicine technologies in the prevention of hypertension. The results of the study and their discussion. The analysis of literary sources has shown that in the context of the progress of information and telecommunication technologies in the healthcare system, a fundamentally new direction has appeared in the organization and provision of medical care to the population - telemedicine, which will ensure the modern level of prevention, detection and treatment of chronic non-communicable diseases, and also determines positive medical, social and economic performance indicators. To date, updates in the legislative framework of the Russian Federation are aimed at ensuring that medical care with the use of telemedicine technologies is more widespread, taking into account the standards of medical care and clinical recommendations. Conclusion. Based on a review of literature sources, it has been established that the modern solution to the problem of improving the quality of medical care for patients, including those with hypertension, diseases is medical care using telemedicine technologies that prove their medical, social and economic effectiveness.

Style APA, Harvard, Vancouver, ISO itp.

Liu, Mengnan, Raoqiong Wang, Ziyi Li, Maryam Mazhar, Gang Luo i Sijin Yang. Danshen decoction in the treatment of heart failure: a systematic review and meta-analysis protocol of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0107.

Pełny tekst źródła

Streszczenie:

Review question / Objective: HF (heart failure) is considered to be the clinical endpoint and the leading cause of death of CVD (cardiovascular diseases). With people's growing desire for a healthy and better life, TCM (traditional Chinese medicine) as an alternative in the prevention and treatment of HF is becoming more popular. The basic and clinical research related to TCM has also been widely concerned by the cardiovascular community of scientists/clinicians. In recent years, a large number of preclinical (in vivo/in vitro) experiments and clinical observation studies have proved the therapeutic efficacy of Danshen decoction in the treatment of HF. However, systematic evaluation and review of the clinical treatment of Danshen decoction is insufficient, leaving objective and quantitative evaluation indicators of Danshen decoction to be inadequate. Therefore, evidence-based studies are urgently needed to demonstrate its efficacy and safety.

Style APA, Harvard, Vancouver, ISO itp.

Best Practices for Cardiovascular Disease Prevention Programs. National Center for Chronic Disease Prevention and Health Promotion, listopad 2022. http://dx.doi.org/10.15620/cdc:122281.

Pełny tekst źródła

Streszczenie:

The Best Practices Guide for CVD Prevention describes and summarizes scientific evidence behind 8 effective strategies for lowering high blood pressure and cholesterol levels that can be implemented in health care systems and that involve community-clinical links. The guide is a resource for state and local health departments, decision makers, public health professionals, and other stakeholders interested in using proven strategies to improve cardiovascular health.

Style APA, Harvard, Vancouver, ISO itp.

Best Practices for Cardiovascular Disease Prevention Programs. National Center for Chronic Disease Prevention and Health Promotion (U.S.)., listopad 2022. http://dx.doi.org/10.15620/cdc:122290.

Pełny tekst źródła

Streszczenie:

Style APA, Harvard, Vancouver, ISO itp.

Proposed national strategies for the prevention of leading work-related diseases and injuries - occupational cardiovascular diseases. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, styczeń 1986. http://dx.doi.org/10.26616/nioshpub89132.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

A situation analysis of the maternal and child health/family planning (MCH/FP) program in Botswana. Population Council, 1996. http://dx.doi.org/10.31899/rh1996.1002.

Pełny tekst źródła

Streszczenie:

Botswana has a rapid annual population growth rate and a high total fertility rate. It also has one of the highest levels of contraceptive use in sub-Saharan Africa. Infant and under-5 mortality rates have fallen, yet maternal mortality remains high. The Government of Botswana has developed an extensive network of health care facilities that provide services through an integrated approach. Family planning (FP) services are available at all three levels of the MOH system (hospitals, clinics, health posts). Services for managing sexually transmitted diseases (STDS) have recently undergone a substantial change with the introduction of the Syndromic Approach to STD management. There is concern about a rapid increase in the number of persons infected with HIV. Although the Government of Botswana continues to make efforts to meet the need for FP, STD, and AIDS services, there remains a large unmet need. The Botswana Population Assistance Project is USAID’s approach to strengthening MCH/FP and STD/AIDS services to improve quality and availability of FP/STD services and expand AIDS prevention measures.

Style APA, Harvard, Vancouver, ISO itp.

Safeguarding through science: Center for Plant Health Science and Technology 2008 Accomplishments. U.S. Department of Agriculture, Animal and Plant Health Inspection Service, grudzień 2009. http://dx.doi.org/10.32747/2009.7296842.aphis.

Pełny tekst źródła

Streszczenie:

The Center for Plant Health Science and Technology (CPHST) was designed and developed to support the regulatory decisions and operations of the Animal and Plant Health Inspection Service’s (APHIS) Plant Protection and Quarantine (PPQ) program through methods development work, scientific investigation, analyses, and technology—all in an effort to safeguard U.S. agriculture and natural resources. This 2008 CPHST Annual Report is intended to offer an in-depth look at the status of its programs and the progress it has made toward the Center’s long-term strategic goals. One of CPHST’s most significant efforts in 2008 was to initiate efforts to improve the Center’s organizational transparency and overall responsiveness to the needs of its stakeholders. As a result of its focus in this area, CPHST is now developing a new workflow process that allows the customers to easily request and monitor projects and ensures that the highest priority projects are funded for successful delivery. This new system will allow CPHST to more dynamically identify the needs of the agency, more effectively allocate and utilize resources, and provide its customers timely information regarding a project’s status. Thus far, while still very much a work in progress, this new process is proving to be successful, and will continue to advance and expand the service to its customers and staff. The considerable and growing concern of homeland security and the management of critical issues drives CPHST to lead the methods development of science-based systems for prevention, preparedness, response, and recovery. CPHST is recognized nationally and internationally for its leadership in scientific developments to battle plant pests and diseases.

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!